Showing results (191-200 of 296) with videos related to

Sort By:
Pageof 30
The Prostate|June 8, 2001
Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differencesL Collette, U E Studer, F H Schröder, et al.
European Urology|April 25, 2006
Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?Martin C Schumacher, Fiona C Burkhard, George N Thalmann, et al.
Urologia Internationalis|March 20, 2010
The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survivalM Spahn, C Weiss, P Bader, et al.
The Journal of Urology|July 18, 2001
Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors alpha1, beta and beta2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractionsH Danuser, R Weiss, D Abel, et al.
The Journal of Urology|October 16, 2007
The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancerClaudia Meissner, Gianluca Giannarini, Martin C Schumacher, et al.
European Urology|January 1, 1993
Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancerU E Studer, M F Fey, A Calderoni, et al.
World Journal of Urology|July 11, 2006
Long-term results of standard procedures in urology: the ileal neobladderRichard E Hautmann, Bjoern G Volkmer, Martin C Schumacher, et al.
The Prostate|June 3, 2008
Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progressionDaniel Peternac, Irena Klima, Marco G Cecchini, et al.
Ecotoxicology and Environmental Safety|September 10, 2010
Effects of exposure water volume, depuration time, and feeding status on vitellogenin mRNA induction in male medaka (Oryzias latipes) exposed to 17 β-estradiolLauren T Moffatt, Chelsea L May, Kirsten E Studer, et al.
Cancer|October 15, 1985
Preliminary results of a Phase I/II study with pi-meson (pion) treatment for bladder cancerU E Studer, C F Von Essen, J B Enderli, et al.
Pageof 30